Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2026-01-17 @ 2:06 PM
Study NCT ID:
NCT02213861
Status:
UNKNOWN
Last Update Posted:
2016-10-20
First Post:
2014-08-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma
Sponsor:
TetraLogic Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11
Start Date Type:
None
Primary Completion Date:
2016-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-10
Completion Date Type:
ESTIMATED
First Submit Date:
2014-08-06
First Submit QC Date:
None
Study First Post Date:
2014-08-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-18
Last Update Post Date:
2016-10-20
Last Update Post Date Type:
ESTIMATED